Innoviva (INVA) Profit After Tax (2010 - 2026)

Innoviva (INVA) reported Profit After Tax of $186.6 million for Q1 2026, up 500.56% on a YoY basis from $31.1 million in Q1 2025, and up 250.12% quarter-over-quarter from -$124.3 million in Q4 2025.

Innoviva (INVA) Profit After Tax (2010 - 2026) Analysis & Trends

Innoviva has reported Profit After Tax for 17 years, with the latest figure at $186.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Profit After Tax rose 500.56% year-over-year to $186.6 million; the trailing twelve-month figure through Mar 2026 stood at $215.9 million (up 378.73% YoY), and the FY2025 full-year result was $271.2 million, up 1059.22% from the prior year.
  • Profit After Tax for Q1 2026 stood at $186.6 million, up from -$124.3 million in the prior quarter.
  • The five-year high for Profit After Tax was $229.3 million in Q3 2022, with the low at -$124.3 million in Q4 2025.
  • Historically, Profit After Tax has averaged $32.4 million across 5 years, with a median of $21.4 million in 2022.
  • The largest YoY upside for Profit After Tax was 7312.04% in 2025 against a maximum downside of 4880.69% in 2025.
  • Innoviva's Profit After Tax stood at -$10.3 million in 2022, then tumbled by 92.43% to -$19.8 million in 2023, then jumped by 113.1% to $2.6 million in 2024, then plunged by 4880.69% to -$124.3 million in 2025, then surged by 250.12% to $186.6 million in 2026.
  • The last three Profit After Tax figures came in at $186.6 million (Q1 2026), -$124.3 million (Q4 2025), and $89.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.90 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.63 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -753,254.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.74 Mn
10 Innoviva 1.65 Bn 1.05 Bn 75.83 Mn 186.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 186.60 Mn
Dec 31, 2025 -124.30 Mn
Sep 30, 2025 89.91 Mn
Jun 30, 2025 63.69 Mn
Mar 31, 2025 -46.58 Mn
Dec 31, 2024 2.60 Mn
Sep 30, 2024 1.21 Mn
Jun 30, 2024 -34.69 Mn
Mar 31, 2024 36.53 Mn
Dec 31, 2023 -19.85 Mn
Sep 30, 2023 82.05 Mn
Jun 30, 2023 1.28 Mn
Mar 31, 2023 34.87 Mn
Dec 31, 2022 -10.31 Mn
Sep 30, 2022 229.35 Mn
Jun 30, 2022 21.37 Mn
Mar 31, 2022 37.86 Mn
Dec 31, 2021 -6.05 Mn
Sep 30, 2021 102.65 Mn
Jun 30, 2021 110.85 Mn